EASEE-PEARL: A Long-Term Registry Observing EASEE® Therapy for Focal Epilepsy in Germany
Real-World Data on the Long-Term Use of EASEE® Therapy in Germany
By capturing treatment data in everyday clinical practice, the EASEE-PEARL study aims to provide valuable insights into the long-term efficacy, safety, and applicability of the EASEE® System in people with treatment-resistant focal epilepsy.
Patient Experiences at the Center
EASEE-PEARL captures important insights into the use of the EASEE® System and its impact on the everyday lives of people with focal epilepsy.
Evidence from Clinical Practice
EASEE-PEARL helps to further improve the long-term care of people with focal epilepsy through practice-based evidence from everyday clinical care.
Long-Term Data on EASEE®
The study provides insights into the efficacy, tolerability, acceptance, and use of EASEE® over a period of three years.
The Study at a Glance
- Indication: Drug-resistant focal epilepsy
- Population: 135 adult patients aged 18 and older
- Intervention: Treatment with the EASEE® System as part of routine clinical care
- Study Design: Multicenter registry study in Germany
- Objective: Evaluation of efficacy, tolerability, and long-term use of the EASEE® System in a real-world setting
Procedure
Inclusion
Baseline
Implantation
Activation
Follow-up
Study End
Clinical Expertise behind EASEE-PEARL
Prof. Dr. med. Bettina Schmitz
Head of the Department of Neurology
Stroke Unit and Berlin Epilepsy Center
Vivantes
Medical Care Center for Neurology
Interested in EASEE-PEARL?
For questions about EASEE-PEARL, the study team at Vivantes Klinikum is happy to help.
